Has Marjorie Maine received payments from drug or device companies?

Yes. Drug and device makers reported $4,328 in general payments to Marjorie Maine across 202 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marjorie Maine did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marjorie Maine come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marjorie Maine

Psychiatric/Mental Health · Tobyhanna, PANPI 1952704215

Payments from drug & device makers

$4,328in general payments, 2019–2025

Across 202 payments — averaging $21.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$895
AbbVie$886
Alkermes, Inc.$352
Supernus Pharmaceuticals, Inc.$345
Lundbeck LLC$298
Neurocrine Biosciences, Inc.$260
plus $1K from 17 others

What the payments were for

Food & beverage$4,23498%
Education$942%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	34	$895
AbbVie(2 entities)	39	$886
Alkermes, Inc.	12	$352
Supernus Pharmaceuticals, Inc.	15	$345
Lundbeck LLC	13	$298
Neurocrine Biosciences, Inc.	11	$260
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$223
Takeda Pharmaceuticals U.S.A., Inc.	18	$218
Teva Pharmaceuticals USA, Inc.	12	$208
Otsuka America Pharmaceutical, Inc.	11	$205
Vanda Pharmaceuticals Inc.	5	$71
Bausch Health US, LLC	3	$70
Eisai Inc.	4	$67
Ironshore Pharmaceuticals Inc.	3	$37
Indivior Inc.	2	$29
Sunovion Pharmaceuticals Inc.	2	$28
Merck	2	$25
Noven Pharmaceuticals, Inc.	1	$23
Biogen	1	$21
Corium, LLC	1	$19
Noven Therapeutics, LLC	1	$17
OWP Pharmaceuticals, Inc.	1	$16
Almatica Pharma LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,328 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lithium Carbonate	13	$104
Zolpidem Tartrate ErZolpidem Tartrate	13	$92
Duloxetine Hcl	13	$80
Gabapentin	15	$77
Buspirone Hcl	13	$62
Clonazepam	27	$47
Lamotrigine	15	$35

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Tobyhanna

Kimberly GarciaAllentown$573K
Cortney SmithWashington$227K
Britney KeplerPittsburgh$158K
Kirstyn KamegBethel Park$136K
Anna DipietroDowningtown$131K
Deena MasciocchiLanghorne$71K
Joseph GagnonChesterbrook$64K
Michelle CohenWashington$62K
Sharon KatzJenkintown$51K
Jennifer BowmanCanonsburg$48K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →